Double Trigger in Patients With Low Proportion of Mature Oocytes
Status:
Recruiting
Trial end date:
2021-02-02
Target enrollment:
Participant gender:
Summary
The aim of this randomized controlled trial is to determine whether co-administration of GnRH
agonist and hCG for final oocyte maturation ( 40 and 34 h prior to oocyte retrieval ,
respectively) can increase the number of mature oocytes in patients with history of low
proportion of mature oocytes in previous IVF cycle triggered by HCG.